LexDanaLexDanabeta
Inventor

David M. Stern

Inventor
Great Neck, NY, US

Overview

49→
Patents
1977–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 49 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A01KAnimal husbandry10%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C12YEnzymes3%
G01FMeasuring volume, volume flow, mass flow or liquid level3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
A61MDevices for introducing media into, or onto, the body1%
PatentTitleYear
10,585,296High speed scanning system with acceleration tracking20208,450,454'Compositions for inhibiting ABAD/ABeta protein interaction'20138,133,866'Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury'20128,128,963'Methods for treating ischemic disorders using carbon monoxide'20128,124,829'Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof'20128,067,371'RAGE G82S-related methods and compositions for treating inflammatory disorders'20117,919,670'Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof'20117,732,400'Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury'20107,700,085'Method for treating symptoms of diabetes'20107,494,972'Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia'20097,258,857'Rage-related methods for treating inflammation'20077,125,675'Method for inhibiting tumor invasion or spreading in a subject'20067,101,838'Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts'20067,081,241'Extracellular rage binding protein (EN-RAGE) and uses thereof'20067,060,870'Transgenic mice over-expressing ABAD and mutant APP in brain as model of Alzheimer\'s disease and uses thereof'20067,026,444'Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof'20066,994,974'Intracellular amyloid-beta binding (ERAB) polypeptide-related assays'20066,969,704'Methods for suppressing early growth response—1protein (Egr-1) to reduce vascular injury in a subject'20056,891,081'Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer\'s disease and uses thereof'20056,825,164'Method to increase cerebral blood flow in amyloid angiopathy'20046,790,443'Method for treating symptoms of diabetes'20046,753,150'Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage'20046,734,168'Endothelial monocyte activating polypeptide II: a mediator which activates host response'20046,677,299'Method to increase cerebral blood flow in amyloid angiopathy'20046,670,136'Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof'20036,563,015'Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof'20036,555,651'Ligand binding site of rage and uses thereof'20036,555,340'Nucleic acid encoding bovine extracellular rage binding protein (en-rage)'20036,465,422'Method for inhibiting tumor invasion or spreading in a subject'20026,391,300'Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation'20026,315,995'Methods for treating an ischemic disorder and improving stroke outcome'20016,316,403'Methods for treating an ischemic disorder and improving stroke outcome'20016,268,479'Intracellular amyloid-beta peptide binding (ERAB) polypeptide'20016,228,837'Endothelial monocyte activating polypeptide II: a mediator which activates host response'20015,968,911'Method of inducing vasorelaxation to treat pulmonary hypertension'19995,839,443'Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation'19985,728,705'Method of inducing vasorelaxation to treat pulmonary hypertension'19985,641,867'Antibody which specifically binds to endothelial-monocyte activating polypeptide II'19975,552,267'Solution for prolonged organ preservation'19965,510,779'Error compensating instrument system with digital communications'19965,426,097'Calreticulin: a novel antithrombotic agent'19955,370,989'Solution for prolonged organ preservation'19945,227,368'Endotoxin-induced thrombosis factor which induces procoagulant activity in endothelial cells'19935,049,878'Two-wire compensated level measuring instrument'19914,885,277'Anticoagulant therapy'19894,851,831'Two-wire level measuring instrument'19894,485,673'Two-wire level measuring instrument'19844,235,106'System and method for obtaining compensated level measurements'19804,005,167'Plasticizing apparatus'1977

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1980–1996Based in Merion Station, PA, US· patent location history
1984–1991Patents assigned to DREXELBROOK ENG CO (3)· patent assignee history
1989–2012Based in Great Neck, NY, US· patent location history
1993–2013Patents assigned to UNIV COLUMBIA (40)· patent assignee history
2007–2013Based in Cincinnati, OH, US· patent location history
2010–2012Patents assigned to CLEVELAND CLINIC FOUNDATION (2)· patent assignee history
2010–2012Based in Augusta, GA, US· patent location history
2011–2013Patents assigned to STERN DAVID M (5)· patent assignee history
2011–2012Patents assigned to SCHMIDT ANN MARIE (3)· patent assignee history
2020Based in Mountain View, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV COLUMBIA401993–2013
STERN DAVID Mself52011–2013
DREXELBROOK ENG CO31984–1991
SCHMIDT ANN MARIE32011–2012
CLEVELAND CLINIC FOUNDATION22010–2012
Locations
LocationPatentsSpan
Great Neck, New York, US361989–2012
Merion Station, Pennsylvania, US51980–1996
Augusta, Georgia, US32010–2012
Cincinnati, OH, US22007–2013
Mountain View, California, US12020